CBI’s 16th Annual Life Sciences Accounting & Reporting Congress

CBI’s 16th Annual Life Sciences Accounting & Reporting Congress
March 16-19, 2020 | Loews Hotel | Philadelphia, PA
www.cbinet.com/accounting

Regulatory reforms, increased complexity and materiality of rebate/discount agreements, continued M&A deals and a dynamic risk environment have leaders in Finance and Accounting on the front lines of critical business decisions and external reporting.

CBI’s 16th Annual Life Sciences Accounting & Reporting Congress, an important event for finance, accounting and business leaders within life sciences, provides in-depth CPE education and networking with nearly 600 professionals.

Visit www.cbinet.com/accounting for further details and to register. Drug Channels readers will save $300 off the standard rate when they use code RJF938 and register prior to January 31st.*

Hot topics include SEC reporting, R&D financing, product pricing and contracting, critical audit matters, GTN, robotic process automation, valuation, collaborations and licensing, capital creation and allocation, SOX compliance, M&A, corporate tax, new product commercialization, FP&A, cybersecurity and data privacy, carve-outs and divestitures, revenue recognition, forecasting and financial planning, leases, and third-party oversight. You’ll return to the office ready to advance your organization to stay ahead in 2020.

Here’s a snapshot of what to expect, and don’t forget to download the latest agenda here.

EXTENSIVE INDUSTRY KNOWLEDGE SHARING AND BENCHMARKING FROM OVER 100 EXPERTS, INCLUDING:

• Chad Cohen, CFO, Adaptive Biotechnologies Corp
• Gina Consylman, CFO, Ironwood Pharmaceuticals
• Patrick Coyle, CFO, Eisai
• Gisele Dion, Chief Accounting Officer, Takeda
• Rita Karachun, Senior VP and Global Controller, Merck
• Kevin Mackay, VP, Controller and Chief Accounting Officer, Pfizer
• Steve Rivera, VP, Global Technical Accounting Advisory Services & Policy, J&J
• Gary Sender, CFO, Nabriva Therapeutics

VALUABLE NETWORKING AND CAREER DEVELOPMENT:

• 14+ hours of specially designed networking events and receptions
• Industry-Only Controllers Roundtable
• Talent Planning, Diversity, Culture & Inclusion Summit
• 12 Acuity Activities and Topic Intensive Workshops
  
• Four company-specific tracks for:
1. Mid-Large Pharma
2. Commercial-Stage Biotech
3. Clinical-Stage Innovators
4. Device and Diagnostic

INFLUENTIAL INSIGHTS FROM REGULATORS AND AUDIT FIRMS:

• John Vanosdall, Deputy Chief Accountant, U.S. SEC
• Kevin Vaugh, Accounting Branch Chief, Office of Life Sciences U.S. SEC
• Russ Golden, Chairman, FASB
• PwC, Deloitte, Ernst & Young, KPMG, CFGI and more!

Visit www.cbinet.com/accounting for further details and to register. Drug Channels readers will save $300 off the standard rate when they use code RJF938 and register prior to January 31st.* CBI will see you there! *Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rate or non-profit rates. Other restrictions may apply.

---

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.